We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Guidance Aims to Minimize ECG Electrode Risks
U.S. FDA Guidance Aims to Minimize ECG Electrode Risks
December 12, 2007
A new draft guidance from the U.S. Food and Drug Administration (FDA) should help manufacturers minimize health risks of electrocardiograph electrodes.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor